Journal Of Clinical Oncology (jco) Podcast

HER3-DXd in EGFR-Mutated NSCLC: HERTHENA-Lung01

Informações:

Synopsis

Dr. Shannon Westin and her guest, Dr. Helena Yu discuss the paper "HERTHENA-Lung01, a Phase 2 Trial of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Following EGFR TKI Therapy and Platinum-Based Chemotherapy" published in the JCO during the World Conference on Lung Cancer in Singapore.